The treatment schedule is shown in Figure 5A. Tumor size was measured on day 8 after the treatment began, and after harvesting the tumors, each sample was examined for the expression of LMP2 protein, MHC class I molecules on the cell surface, and tumor-infiltrating lymphocytes (TILs) (Figure S4). Here, PSMB9 is linked to neoplasm.